Comment on 'Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial'.

Loas, Gwenolé; Le Corre, Pascal

Loas, Gwenolé; Le Corre, Pascal.

Loas G; Department of Psychiatry, Hôpital Erasme, Université libre de Bruxelles (ULB), Brussels, Belgium.
Le Corre P; Laboratoire de Biopharmacie et Pharmacie Clinique, Faculté de Pharmacie, Université de Rennes 1, Rennes, France.

Int J Clin Pract ; 75(12): e14957, 2021 12.

Article in English | MEDLINE | ID: covidwho-1583549

Subject(s)

COVID-19; Hypertension; Amlodipine/therapeutic use; Antihypertensive Agents/therapeutic use; Humans; Hypertension/drug therapy; Losartan/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypertension Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Int J Clin Pract Journal subject: Medicine Year: 2021 Document Type: Article Affiliation country: Ijcp.14957

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google